Most Patients Discontinue GLP-1 Drugs Within a Year, Higher Dropout for Weight Loss Users A new study found that nearly half of patients with type 2 diabetes and almost two-thirds of those without the condition discontinue glucagon-like peptide-1 receptor agonists (GLP-1 RAs) within a year of starting treatment
That said, while sequential and year-over-year growth is expected to continue, we do expect uneven trends in sexual health as we navigate transitions in the treatment mix, which we believe is temporary as new daily personalized solutions gain traction
First, a little about gut peptides Lets start at the beginning
Gobburu JV, Agers H, Jusko WJ, Ynddal L (1999)
The medication also improves insulin sensitivity to regulate blood sugar, which can impact how effectively the body uses fat for energy
If travel is a recurring concern, our GLP-1 travel and storage guide can help you prepare for different trip lengths